Cities such as London, San Francisco and New York are registered each time
fewer new AIDS cases and experts attributed much of this achievement to the pill: pre-exposure prophylaxis, better known as PrEP.
If taken daily, PrEP reduces the chances of engaging HIV through sex by more than 90% or 70% using unsterilized needles or by using more people, according to the Centers for Disease Control and Prevention. US Disease Prevention (CDC for acronym in English).
The US-based pharmaceutical company Gilead Sciences began selling in 2012 under the Truvada brand.
And three years later, the World Health Organization (WHO) began recommending its use to prevent HIV among high-risk groups to contract HIV, such as homosexuals, bisexual men and their partners, sex workers or sex workers. couples of someone infected with this virus.
But although its results have already been observed in developed countries, the high cost of this treatment has kept away from the most vulnerable areas.
Chile, for example, is one of the 10 countries in the world where new cases of HIV patients have increased by more than 50% between 2010 and 2017, according to the United Nations Program on HIV / AIDS (UNAIDS).
And there PrEP costs between US $ 575 and US $ 645 per month, according to the press in that country.
However, from the first quarter of 2019, the government will distribute it free as part of an ambitious national AIDS response plan, as new infections doubled between 2010 and 2017, according to the Public Health Institute of Chile (ISP).
But how does it work?
PrEP contains emtricitabine and tenofovir, two drugs that are also used in antiretroviral drugs because they reduce the amount of blood in the blood and prevent it from multiplying.
It does not work like a vaccine because it does not generate antibodies, but its daily dose is necessary so that emtricitabine and tenofovir are present in the blood at the moment of infection and prevent HIV from being found in the body, CDC explains. website
However, PrEP is not for everyone. Before you start taking it, it must be ruled out that the patient is already infected with the virus. It is also necessary to confirm the good state of the kidneys and the liver, because the pill may cause disorders in these organs.
Experts recommend limiting its use to those at risk of contracting HIV because treatment can lead to adverse effects such as nausea, stomach or headaches, and in more extreme cases, the accumulation of lactic acid in the blood.
In addition, those suffering from hepatitis B should be particularly careful, because if they start to use Truvada and then stop treatment, it is very likely that hepatitis will deteriorate.
Not 100% sure
Taking PrEP does not mean that other prevention methods can be ruled out. The pill does not protect against other sexually transmitted diseases such as gonorrhea, syphilis, or genital herpes, which is incurable.
Neither is 100% sure. Although rare, there are at least five cases of people who have contracted HIV despite taking Truvada and two more cases in which it can not be completely excluded that patients acquired the virus before starting to take the pill, according to the AIDS- the Aidsmap.
There are several exceptions among the thousands of people using PrEP. Nevertheless, treatment must be accompanied by other preventive methods, such as condoms and periodic HIV tests.